Pharmacotherapy and treatment options for HIV-associated nephropathy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2018-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14656566.2017.1416099PMID 29224373PMCID PMC6381591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

  2018cited by this paper
• APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors

  2016cited by this paper
• AJKD Atlas of Renal Pathology: HIV-Associated Nephropathy (HIVAN).

  2016cited by this paper
• Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.

  2016cited by this paper
• HIV-associated renal disease - an overview.

  2016cited by this paper
• Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors

  2016cited by this paper
• Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.

  2015influential reference
• Transplantation in resource-limited setting: using HIV-positive donors for HIV-positive patients

  2015cited by this paper
• Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy

  2015cited by this paper
• HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment

  2015cited by this paper
• HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years.

  2015cited by this paper
• The kidney as a reservoir for HIV-1 after renal transplantation.

  2014cited by this paper
• Predictors of HIV-associated nephropathy

  2014cited by this paper
• Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

  2014influential reference
• [Inhibition of the renin-angiotensin system in HIV nephropathy].

  2014cited by this paper
• HIV infection: epidemiology, pathogenesis, treatment, and prevention.

  2014cited by this paper
• End-stage renal disease from human immunodeficiency virus–associated nephropathy in the United States, 2001 through 2010.

  2014cited by this paper
• Long-term risk of mortality for acute kidney injury in HIV-infected patients: a cohort analysis

  2013cited by this paper
• Interventions for HIV-associated nephropathy.

  2013cited by this paper
• ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.

  2012cited by this paper
• Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.

  2012cited by this paper
• The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations.

  2012cited by this paper
• HIV-associated kidney glomerular diseases: changes with time and HAART.

  2012cited by this paper
• HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathologic characteristics

  2012cited by this paper
• HIV-associated nephropathy: a diagnosis in evolution.

  2012cited by this paper
• APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

  2011cited by this paper
• HIV-associated nephropathy: pathogenesis

  2011cited by this paper
• Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

  2010cited by this paper
• Outcomes of kidney transplantation in HIV-infected recipients.

  2010cited by this paper
• Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

  2010cited by this paper
• Renal transplantation in patients with HIV

  2009cited by this paper
• Antiretroviral therapy improves renal function among HIV-infected Ugandans.

  2008influential reference
• Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease

  2008influential reference
• HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy.

  2008cited by this paper
• HIV‐Infected Liver and Kidney Transplant Recipients: 1‐ and 3‐Year Outcomes

  2008cited by this paper
• Uniquely South African: time to consider offering HIV-positive donor kidneys to HIV-infected renal failure patients?

  2008cited by this paper
• Acute kidney injury in HIV-infected patients.

  2008cited by this paper
• Observations on a Cohort of HIV-Infected Patients Undergoing Native Renal Biopsy

  2008cited by this paper
• Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

  2007cited by this paper
• HIV-Infected Liver and Kidney Transplant Recipients : 1-and 3-Year Outcomes

  2007cited by this paper
• HIV-Positive Renal Recipients Can Achieve Survival Rates Similar to Those of HIV-Negative Patients

  2006cited by this paper
• Antiretroviral therapy in the treatment of HIV-associated nephropathy.

  2006influential reference
• HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients.

  2006cited by this paper
• Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy.

  2005cited by this paper
• Pharmacotherapy for Human Immunodeficiency Virus‐Associated Nephropathy

  2005cited by this paper
• The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.

  2004cited by this paper
• Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

  2004cited by this paper
• HIV Drug Resistance

  2004cited by this paper
• Sonography as a Predictor of Human Immunodeficiency Virus–Associated Nephropathy

  2004cited by this paper
• Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition.

  2003cited by this paper
• Observations on HIV‐Associated Renal Disease in the Era of Highly Active Antiretroviral Therapy

  2002influential reference
• Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987‐1999

  2002cited by this paper
• Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

  2001cited by this paper
• Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.

  2001cited by this paper
• Renal epithelium is a previously unrecognized site of HIV-1 infection.

  2000cited by this paper
• Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids.

  2000cited by this paper
• Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

  2000cited by this paper
• [Renal insufficiency with AIDS: ultrasonographic aspects].

  1998cited by this paper
• Captopril prevents nephropathy in HIV-transgenic mice.

  1998cited by this paper
• Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy.

  1998cited by this paper
• INSUFFISANCE RENALE ASSOCIEE AU SIDA : ASPECTS ECHOGRAPHIQUES

  1998cited by this paper
• Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy.

  1997cited by this paper
• Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy.

  1996cited by this paper
• Captopril and renal survival in patients with human immunodeficiency virus nephropathy.

  1996cited by this paper
• Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS.

  1995cited by this paper
• Increased renal cortical echogenicity in HIV positive subjects.

  1994cited by this paper
• Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy.

  1994cited by this paper
• Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: a case report.

  1994cited by this paper
• Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

  1984cited by this paper
• Renal disease in patients with AIDS: a clinicopathologic study.

  1984cited by this paper
• Glomerular lesions in the acquired immunodeficiency syndrome.

  1984cited by this paper

• Point-of-care creatinine-based eGFR (StatSensor) in detecting kidney dysfunction (KD) among people living with HIV in Tanzania

  2025cites this paper
• PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy

  2024cites this paper
• Higher prevalence of kidney function impairment among older people living with HIV in Uganda

  2024cites this paper
• Updates on HIV and Kidney Disease

  2023cites this paper
• Health inequities in dialysis care: A scoping review

  2023cites this paper
• ART and Serum albumin are influencing factors of the 5-year survival rate of people living with HIV undergoing maintenance hemodialysis caused by HIV: A cohort study

  2023cites this paper
• Deciphering the True Immunologic Risk in Renal Transplantation in Patients With HIV.

  2023cites this paper
• Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals – A Qualitative Systematic Review

  2022cites this paper
• HIV-associated nephropathy in children: challenges in a resource-limited setting

  2022influential citation
• Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients

  2021cites this paper
• Discontinuation of Intermittent Hemodialysis in HIV-Associated Nephropathy Following Initiation of Antiretroviral Therapy

  2021cites this paper
• The Association between Serum Creatinine, HIV-Infection and Metabolic Variables in Patients Living with Diabetes Mellitus

  2021cites this paper
• Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights from the Renin-Angiotensin-Aldosterone System.

  2021cites this paper
• APOL1 risk variants and the development of HIV‐associated nephropathy

  2020cites this paper
• Pharmacotherapeutic options for kidney disease in HIV positive patients

  2020cites this paper